BDBM173886 US9688645, 1-1
SMILES: CC(C)[C@H]1COCCCCOc2ccc(C[C@@H](NC(=O)N[C@@H](CCCCN)C(O)=O)C(=O)N1)cc2
InChI Key: InChIKey=LULOJIQVOUOYMX-BHDDXSALSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Carboxypeptidase B2 isoform A (Homo sapiens (Human)) | BDBM173886 (US9688645, 1-1) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6 | n/a | n/a | n/a | n/a | 7.4 | 25 |
SANOFI US Patent | Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI Activity Kit from American Diagnostica (Pr. No. 874). This ... | US Patent US9688645 (2017) BindingDB Entry DOI: 10.7270/Q2PV6HJ3 | |||||||||||
More data for this Ligand-Target Pair |